Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapy

Publication Date

2026

Content Type

article

PubMed ID:

42113041

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS